Matching Insulin to Patient: How to Make the Best Use of Premixed Insulin Analog Formulations
Abstract
When prescribing, health care professionals have to weigh multiple options in terms of efficacy, cost, safety, practical patient-centered issues, and our precious, limited time. Innovations in insulin therapy for the treatment of type 2 diabetes include not only the development of premixed insulin analogs but easy-to-use delivery systems as well. This article is intended as a guide for defining the advantages and disadvantages of premixed analogs with a focus on identifying patients who would benefit from using them.
1 Virginia Peragallo-Dittko, APRN, BC-ADM, CDE, has been the director of the Diabetes Education Center at Winthrop-University Hospital in Mineola, NY, since 1985. She holds academic appointments as clinical associate faculty for graduate education. She serves as editor-in-chief of program publications for the American Diabetes Association. In 1990, she was named Diabetes Educator of the Year by the American Association of Diabetes Educators and was named 2002 Diabetes Educator of the Year and 2004 Administrator of the Year by the Metropolitan New York Association of Diabetes Educators. She also serves on the Education Council for the National Diabetes Education Initiative. She serves on continuing education advisory boards for Novo-Nordisk Inc. and Eli Lilly and Company. Although this article is her own work, Novo-Nordisk provided editorial support of this manuscript.
ABSTRACT